MADISON, Wis., April 16 — Promega Corporation, a Madison, Wisconsin-based life science tools company, will present new technologies for cell health, target engagement and oncology diagnostics at the AACR Annual Meeting 2026 in San Diego, April 17-22. Researchers attending the conference can explore tools spanning oncology research, drug discovery and diagnostics workflows at Booth #2229 in the San Diego Convention Center.
Topics to be discussed at the conference include:
- Lumit® hKi-67 Immunoassay for Cell Proliferation: A plate-based assay for tracking a well-known marker of cell proliferation
- TarSeer™ BRETSA™ Target Engagement System: A cellular, tracer-free, bioluminescence-resonance energy transfer (BRET)-based system that detects compound-protein interactions
- Microsatellite Instability (MSI) Companion Diagnostics: Promega OncoMate® MSI Dx Analysis System recently received regulatory approvals from the U.S. FDA and the NMPA in China.
- Automated Nucleic Acid Extraction on KingFisher™ Instruments: Promega has released preconfigured protocols for implementing Maxwell® HT purification chemistry on KingFisher™ Flex and Apex
Promega scientists will also be presenting thirteen research posters during the event, including the first reveal of the company’s red-shifted NanoPrism™ luciferase. Highlights include:
- Two-color bioluminescence analyses pairing NanoLuc® and red-shifted NanoPrism™ luciferases: Sunday April 19, 2:00 – 5:00 pm | Section 13, Board 6, Abstract #288
- BRETSA: A BRET-based assay for ultra-sensitive measurement of target engagement through protein denaturation in live cells: Tuesday, April 21, 2:00 – 5:00 pm | Section 39, Board 27, Abstract #6427
- Lumit-based profiling of degrader dynamics reveals signaling-dependent, cell context-specific sensitivity to degraders: Tuesday, April 21, 2:00 – 5:00 pm | Section 15, Board 26, Abstract #5799
